Biography

Dr. Kehinde (Ken) Ajayi assists in preparing and prosecuting patent applications and managing patent portfolios for various types of clients in the chemical and pharmaceutical industries. His graduate study and multidisciplinary background provide extensive knowledge in a wide range of areas including organic and medicinal chemistry, biochemistry, drug discovery, computer-assisted molecular modeling, molecular biology, and pharmaceuticals.

Background and Credentials

Prior to joining Marshall, Gerstein & Borun, Dr. Ajayi was a research scientist for a major pharmaceutical company. There, he designed, synthesized, and characterized small-molecule compounds to facilitate preclinical development of treatments for Huntington’s disease and cystic fibrosis.

Prior to his experience at the pharmaceutical company, Dr. Ajayi was a medicinal chemistry postdoctoral fellow at the California Institute for Biomedical Research, where he engaged in hit-to-lead and lead optimization efforts to develop potential drugs for type 2 diabetes, tuberculosis, breast and skin cancer, spinal muscular atrophy, and inflammatory bowel disease. He was also a postdoctoral research fellow at the University of Pennsylvania, where he designed and optimized new catalytic reactions for the synthesis of heterocyclic, drug-like molecules. Dr. Ajayi also worked as a consultant for a start-up pharmaceutical company to design and develop novel scaffolds for the controlled release of active compounds.

Dr. Ajayi earned his Ph.D. in organic chemistry from Rutgers, the State University of New Jersey. He received his B.S. in chemistry and his B.A. in philosophy from the University of Connecticut.

Education

  • Rutgers, the State University of New Jersey (Ph.D.)
    • Organic Chemistry
  • University of Connecticut (B.S.)
    • Chemistry
  • University of Connecticut (B.A.)
    • Philosophy

Bar Admissions

  • U.S. Patent and Trademark Office

Publications and Presentations

  • “Compounds for Treatment of Drug Resistant and Persistent Tuberculosis.” Co-inventor, PCT WO/2014/190199, 2014.
  • “Oxidative Condensations to Form Benzimidazole-Substituted Potassium Organotrifluoroborates.” Co-author, Organic Letters 2012, 14, 4242–4245.
  • “Intramolecular α-Glucosaminidation: Synthesis of Mycothiol.” Co-author, Organic Letters 2010, 12, 2630–2633.
  • “Intramolecular glucosamine alpha-glycosylation: Mycothiol.” Washington, DC, Abstracts of Papers, 238th American Chemical Society National Meeting, August 2009.
  • “Design and Synthesis of a Controlled Release Drug Conjugate for Multi-day Delivery of Actives.” Copenhagen, Denmark, Abstracts, 26th Controlled Release Society Annual Meeting, July 2009.

Click here to see additional Publications and Presentations.

Community and Professional Involvement

  • American Chemical Society
  • American Intellectual Property Law Association